NCT06646029 Pilot Study on The Effectiveness of Relative Motion Orthosis in Finger Motion
| NCT ID | NCT06646029 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Proximal Interphalangeal Joint Stiffness |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-12-07 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2024-12-07 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this feasibility pilot study is to determine the effectiveness of Relative Motion Orthosis (RMO) in regaining finger range of motion compared to standard care in patients diagnosed with Proximal Interphalangeal (PIP) stiffness with an extension lag secondary to finger injury. Participants will be enrolled and randomized into groups receiving either standard conservative interventions or standard interventions in addition to the RMO. The primary endpoint is to evaluate the efficacy of relative motion orthosis in PIP ROM using clinical scoring and physical exam findings.
Eligibility Criteria
Inclusion Criteria: * Age range 18-80 * Any gender * Any Proximal Interphalangeal (PIP) injury that causes reduced PIP Active Range of Motion (AROM) in extension * Right or left hand injury * Level of Chronicity (4 weeks - 6 months) * Able to follow instructions Exclusion Criteria: * PIP with hard end feel (feels they need serial casting) - level of chronicity * Any digital nerve injury / skin laceration that can prevent the patient from using the orthosis * Severe arthropathy * Literacy deficits: patients need to be able to follow verbal and written instructions independently to minimize risks and improve outcomes from care.
Contact & Investigator
Natalia Ruiz, DPT
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT06646029 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Proximal Interphalangeal Joint Stiffness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06646029 currently recruiting?
Yes, NCT06646029 is actively recruiting participants. Contact the research team at Natalia.ruiz@nyulangone.org for enrollment information.
Where is the NCT06646029 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06646029 clinical trial?
NCT06646029 is sponsored by NYU Langone Health. The principal investigator is Natalia Ruiz, DPT at NYU Langone Health. The trial plans to enroll 64 participants.